Skip to main content
. 2014 Aug 21;8(8):e3054. doi: 10.1371/journal.pntd.0003054

Figure 8. Visualisation of ex vivo brain BLI data obtained from mice infected with different luminescent strains.

Figure 8

At 26 days post-infection for T.b. brucei AnTaR 1 and T.b. rhodesiense RUMPHI and at 43 and 60 days post-infection for T.b. gambiense 348 BT brains were extracted and immersed in PBSG and substrate. (A–B) T.b. gambiense 348 BT CBR, CPA-treated, with D-luciferin; (C) T.b. gambiense 348 BT CBR, untreated, with D-luciferin ;(D) uninfected with D-luciferin; (E) T.b. gambiense 348 BT RLuc, CPA-treated with ViviRen; (F–H) T.b. rhodesiense RUMPHI CBR with D-luciferin; (I) T.b. brucei AnTaR 1 CBR with D-luciferin; (J) T.b. brucei AnTaR 1 P9 with D-luciferin.